The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 216, Issue suppl_9, Pages S847-S850
Publisher
Oxford University Press (OUP)
Online
2017-08-18
DOI
10.1093/infdis/jix430
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment options after virological failure of first-line tenofovir-based regimens in South Africa
- (2016) Maria Casadellà et al. AIDS
- Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure
- (2016) Fred Kyeyune et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced disease
- (2015) Maria Casadellà et al. AIDS
- Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
- (2015) L. Marije Hofstra et al. CLINICAL INFECTIOUS DISEASES
- Identification of minority resistance mutations in the HIV-1 integrase coding region using next generation sequencing
- (2015) Jannik Fonager et al. JOURNAL OF CLINICAL VIROLOGY
- Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy
- (2015) Masako Nishizawa et al. PLoS One
- Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure
- (2014) Sofiane Mohamed et al. AIDS
- Sensitive Deep-Sequencing-Based HIV-1 Genotyping Assay To Simultaneously Determine Susceptibility to Protease, Reverse Transcriptase, Integrase, and Maturation Inhibitors, as Well as HIV-1 Coreceptor Tropism
- (2014) Richard M. Gibson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing
- (2014) Alessandro Cozzi-Lepri et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cost-efficient HIV-1 drug resistance surveillance using multiplexed high-throughput amplicon sequencing: implications for use in low- and middle-income countries
- (2014) H. Ekici et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Low-Frequency Nevirapine (NVP)–Resistant HIV-1 Variants Are Not Associated With Failure of Antiretroviral Therapy in Women Without Prior Exposure to Single-Dose NVP
- (2014) Valerie F. Boltz et al. JOURNAL OF INFECTIOUS DISEASES
- Comparison of Illumina and 454 Deep Sequencing in Participants Failing Raltegravir-Based Antiretroviral Therapy
- (2014) Jonathan Z. Li et al. PLoS One
- Contribution of Human Immunodeficiency Virus Type 1 Minority Variants to Reduced Drug Susceptibility in Patients on an Integrase Strand Transfer Inhibitor-Based Therapy
- (2014) Richard M. Gibson et al. PLoS One
- Simultaneous and sensitive detection of human immunodeficiency virus type 1 (HIV) drug resistant genotypes by multiplex oligonucleotide ligation assay
- (2013) Giovanina M. Ellis et al. JOURNAL OF VIROLOGICAL METHODS
- HIV-1 Antiretroviral Resistance
- (2012) Michele W. Tang et al. DRUGS
- Longitudinal analysis of integrase N155H variants in heavily treated patients failing raltegravir-based regimens
- (2012) HL Nguyen et al. HIV MEDICINE
- Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing
- (2012) Daniele Armenia et al. JOURNAL OF INFECTIOUS DISEASES
- Deep Sequencing Reveals Minor Protease Resistance Mutations in Patients Failing a Protease Inhibitor Regimen
- (2012) R. Fisher et al. JOURNAL OF VIROLOGY
- Virologic Failures on Initial Boosted-PI Regimen Infrequently Possess Low-Level Variants with Major PI Resistance Mutations by Ultra-Deep Sequencing
- (2012) Max Lataillade et al. PLoS One
- Low-Cost Ultra-Wide Genotyping Using Roche/454 Pyrosequencing for Surveillance of HIV Drug Resistance
- (2012) Dawn M. Dudley et al. PLoS One
- A Genotypic Test for HIV-1 Tropism Combining Sanger Sequencing with Ultradeep Sequencing Predicts Virologic Response in Treatment-Experienced Patients
- (2012) Ron M. Kagan et al. PLoS One
- Switching between raltegravir resistance pathways analyzed by deep sequencing
- (2011) Rithun Mukherjee et al. AIDS
- Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure
- (2011) Jonathan Z. Li et al. AIDS
- Deep V3 Sequencing for HIV Type 1 Tropism in Treatment-Naive Patients: A Reanalysis of the MERIT Trial of Maraviroc
- (2011) Luke C. Swenson et al. CLINICAL INFECTIOUS DISEASES
- Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure
- (2011) Jonathan Z. Li JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine
- (2011) V. F. Boltz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors
- (2010) Charlotte Charpentier et al. AIDS
- Analysis of Low-Frequency Mutations Associated with Drug Resistance to Raltegravir before Antiretroviral Treatment
- (2010) Jia Liu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure
- (2010) Francisco M. Codoñer et al. ANTIVIRAL RESEARCH
- Transmission of HIV‐1 Drug‐Resistant Variants: Prevalence and Effect on Treatment Outcome
- (2010) Martin R. Jakobsen et al. CLINICAL INFECTIOUS DISEASES
- Efficient Suppression of Minority Drug‐Resistant HIV Type 1 (HIV‐1) Variants Present at Primary HIV‐1 Infection by Ritonavir‐Boosted Protease Inhibitor–Containing Antiretroviral Therapy
- (2010) Karin J. Metzner et al. JOURNAL OF INFECTIOUS DISEASES
- Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naïve Subjects in the CASTLE Study
- (2010) Max Lataillade et al. PLoS One
- The Evolutionary Analysis of Emerging Low Frequency HIV-1 CXCR4 Using Variants through Time—An Ultra-Deep Approach
- (2010) John Archer et al. PLoS Computational Biology
- Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing
- (2009) John Archer et al. AIDS
- Persistent Minority K103N Mutations among Women Exposed to Single‐Dose Nevirapine and Virologic Response to Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Therapy
- (2009) Ashraf Coovadia et al. CLINICAL INFECTIOUS DISEASES
- Quantitative Deep Sequencing Reveals Dynamic HIV-1 Escape and Large Population Shifts during CCR5 Antagonist Therapy In Vivo
- (2009) Athe M. N. Tsibris et al. PLoS One
- Current tests to evaluate HIV-1 coreceptor tropism
- (2009) Justine D Rose et al. Current Opinion in HIV and AIDS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More